Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 449


Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.

Luker KE, Lewin SA, Mihalko LA, Schmidt BT, Winkler JS, Coggins NL, Thomas DG, Luker GD.

Oncogene. 2012 Nov 8;31(45):4750-8. doi: 10.1038/onc.2011.633. Epub 2012 Jan 23.


Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.

Hernandez L, Magalhaes MA, Coniglio SJ, Condeelis JS, Segall JE.

Breast Cancer Res. 2011;13(6):R128. doi: 10.1186/bcr3074. Epub 2011 Dec 9.


Expression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID mice.

Brennecke P, Arlt MJ, Muff R, Campanile C, Gvozdenovic A, Husmann K, Holzwarth N, Cameroni E, Ehrensperger F, Thelen M, Born W, Fuchs B.

PLoS One. 2013 Sep 10;8(9):e74045. doi: 10.1371/journal.pone.0074045. eCollection 2013.


C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.

Wani N, Nasser MW, Ahirwar DK, Zhao H, Miao Z, Shilo K, Ganju RK.

Breast Cancer Res. 2014 May 29;16(3):R54. doi: 10.1186/bcr3665.


Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.

Wu W, Qian L, Chen X, Ding B.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13217-24. eCollection 2015.


Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.

Boudot A, Kerdivel G, Habauzit D, Eeckhoute J, Le Dily F, Flouriot G, Samson M, Pakdel F.

PLoS One. 2011;6(6):e20898. doi: 10.1371/journal.pone.0020898. Epub 2011 Jun 10.


Imaging ligand-dependent activation of CXCR7.

Luker KE, Gupta M, Steele JM, Foerster BR, Luker GD.

Neoplasia. 2009 Oct;11(10):1022-35.


Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands.

Luker KE, Steele JM, Mihalko LA, Ray P, Luker GD.

Oncogene. 2010 Aug 12;29(32):4599-610. doi: 10.1038/onc.2010.212. Epub 2010 Jun 7.


CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells.

Choi YH, Burdick MD, Strieter BA, Mehrad B, Strieter RM.

Mol Cancer Res. 2014 Jan;12(1):38-47. doi: 10.1158/1541-7786.MCR-12-0334. Epub 2013 Sep 11.


Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.

Qiao N, Wang L, Wang T, Li H.

Tumour Biol. 2016 Jun;37(6):8169-79. doi: 10.1007/s13277-015-4686-2. Epub 2015 Dec 29.


Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.

Hsiao JJ, Ng BH, Smits MM, Wang J, Jasavala RJ, Martinez HD, Lee J, Alston JJ, Misonou H, Trimmer JS, Wright ME.

BMC Cancer. 2015 Mar 31;15:204. doi: 10.1186/s12885-015-1201-5.


Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7.

Luker K, Gupta M, Luker G.

Biotechniques. 2009 Jul;47(1):625-32. doi: 10.2144/000113126.


Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.

Liberman J, Sartelet H, Flahaut M, Mühlethaler-Mottet A, Coulon A, Nyalendo C, Vassal G, Joseph JM, Gross N.

PLoS One. 2012;7(8):e43665. doi: 10.1371/journal.pone.0043665. Epub 2012 Aug 20.


The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow.

Shakir M, Tang D, Zeh HJ, Tang SW, Anderson CJ, Bahary N, Lotze MT.

Pancreas. 2015 May;44(4):528-34. doi: 10.1097/MPA.0000000000000298. Review.


Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.

Saha A, Ahn S, Blando J, Su F, Kolonin MG, DiGiovanni J.

Cancer Res. 2017 Sep 15;77(18):5158-5168. doi: 10.1158/0008-5472.CAN-17-0284. Epub 2017 Jul 7.


Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells.

Liu C, Pham K, Luo D, Reynolds BA, Hothi P, Foltz G, Harrison JK.

PLoS One. 2013;8(3):e59750. doi: 10.1371/journal.pone.0059750. Epub 2013 Mar 21.


Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.

Hattermann K, Holzenburg E, Hans F, Lucius R, Held-Feindt J, Mentlein R.

Cell Tissue Res. 2014 Jul;357(1):253-66. doi: 10.1007/s00441-014-1823-y. Epub 2014 Apr 26.


The CXCR4/CXCR7/CXCL12 Axis Is Involved in a Secondary but Complex Control of Neuroblastoma Metastatic Cell Homing.

Mühlethaler-Mottet A, Liberman J, Ascenção K, Flahaut M, Balmas Bourloud K, Yan P, Jauquier N, Gross N, Joseph JM.

PLoS One. 2015 May 8;10(5):e0125616. doi: 10.1371/journal.pone.0125616. eCollection 2015.


Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway.

Xu D, Li R, Wu J, Jiang L, Zhong HA.

Curr Top Med Chem. 2016;16(13):1441-51. Review.


Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.

Heinrich EL, Lee W, Lu J, Lowy AM, Kim J.

J Transl Med. 2012 Apr 2;10:68. doi: 10.1186/1479-5876-10-68.

Supplemental Content

Support Center